Показано 0 из 0
Дата |
---|
17.06.2019 |
07.06.2019 |
03.06.2019 |
20.05.2019 |
02.05.2019 |
30.04.2019 |
29.04.2019 |
26.04.2019 |
16.04.2019 |
08.04.2019 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
|
|
|
31.12
|
|
|
23 246.64
|
|
|
|
|
|
|
34.50
|
|
|
17 871.00
|
|
|
|
|
|
|
35.28
|
|
|
551 708.64
|
|
|
|
|
|
|
36.68
|
|
|
2 677.64
|
|
|
|
|
|
|
39.10
|
|
|
153 272.00
|
|
|
|
|
|
|
39.22
|
|
|
154 213.04
|
|
|
|
|
|
|
39.80
|
|
|
39 601.00
|
|
|
|
|
|
|
39.40
|
|
|
341 519.20
|
|
|
|
|
|
|
39.22
|
|
|
290 894.74
|
|
|
|
|
|
|
41.68
|
|
|
347 444.48
|
|
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.